Fixation Training for Macular Degeneration

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: National Eye Institute (NEI)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a special type of eye training, known as fixation training, can help individuals with macular degeneration or similar eye conditions improve their vision. The focus is on reducing fixational eye movements, which are quick and often exaggerated movements that might worsen vision. Participants will undergo several training sessions to practice keeping their eyes steady on a target. This trial suits those with significant vision issues due to macular disorders in both eyes, especially if they have trouble with central vision.

As an unphased trial, this study offers participants a unique opportunity to potentially improve their vision through innovative training techniques.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this fixation training is safe for people with central vision loss?

Research shows that fixation training is usually easy for participants to handle. This training involves simple exercises where participants focus on a target while researchers monitor and adjust eye movements. It is non-invasive, meaning it doesn't involve surgery or medication, which often results in fewer side effects.

In studies of similar non-invasive eye training methods, participants have not reported any major problems. Since this trial does not involve any drugs or surgery, the risks remain low. However, as with any study, participants might feel a bit uncomfortable or tired from the training sessions, which last about an hour each. This is normal for activities requiring intense focus but isn't considered harmful.

Overall, fixation training is considered safe because it doesn't involve surgery or medication, and similar research has not shown any significant side effects.12345

Why are researchers excited about this trial?

Researchers are excited about fixation training for macular degeneration because it offers a novel approach by focusing on eye movement adaptation rather than directly treating the retina. Unlike standard treatments like anti-VEGF injections or laser therapy, which target the eye's physical structure to slow disease progression, this method aims to optimize how patients use their remaining vision. By training the brain to adjust microsaccades—tiny, rapid eye movements—patients might improve their visual stability and clarity. This innovative focus on neuroadaptation could enhance patients' quality of life without the invasiveness of traditional treatments.

What evidence suggests that fixation training is effective for macular degeneration?

Research suggests that fixation training, which participants in this trial will undergo, might improve vision in people with age-related macular degeneration (AMD) and Stargardt disease. This training teaches individuals to better control their small, quick eye movements, known as microsaccades, to steady their vision. Although direct proof is lacking, some studies indicate that reducing these movements could enhance visual acuity. Early results from eye movement training are promising, showing that it can help individuals with macular diseases perform visual tasks more effectively. This method relies on the idea that controlling eye movements can lead to clearer vision.678910

Are You a Good Fit for This Trial?

This trial is for individuals with central vision loss, often due to conditions like age-related macular degeneration (AMD) or Stargardt disease. Participants should have abnormal fixational eye movements compared to those with normal vision.

Inclusion Criteria

I am 18 or older with normal vision, minimal cataracts, and no retinal diseases.
I am over 18, have a macular disorder in both eyes, with a vision of 20/400 or better in one eye, and minimal cataracts.

Exclusion Criteria

I am under 18 with vision issues not corrected to 20/20, have mild cataracts or worse, poor contrast sensitivity, stereoacuity over 40 seconds of arc, or any retinal disease.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Participants undergo fixation training to modify fixational eye movements, consisting of 5-6 sessions of training (about 1 hour each).

5-6 weeks
5-6 visits (in-person)

Follow-up

Participants are monitored for changes in fixation stability and functional vision after training.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Fixation training
Trial Overview The study tests whether fixation training can reduce exaggerated fixational eye movements in people with central vision loss, potentially improving their visual performance and stability of gaze.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Microsaccade adaptationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

National Eye Institute (NEI)

Lead Sponsor

Trials
572
Recruited
1,320,000+

Citations

Training to Modify Fixational Eye Movements for Optimizing ...... age-related macular degeneration (AMD) and Stargardt disease. The clinical wisdom is that exaggerated fixational eye movements are ...
Efficacy of biofeedback rehabilitation based on visual ...The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The ...
How effective is eccentric viewing training for AMD?... age-related macular degeneration (AMD). Give me some background first. For individuals with macular disease ... training may help people with ...
Effectiveness of eccentric viewing training for daily visual ...The keywords for searching were "age-related macular degeneration" and "eccentric viewing", "eccentric fixation", "peripheral vision" or " ...
Training eye movements for visual search in individuals with ...Preferred retinal locus development in patients with macular disease. ... Eye-movement training for reading in patients with age-related macular degeneration.
Enhancing the Functional Performance of Patients with Late ...Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146 ...
Implantable vision-enhancing devices and postoperative ...Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Age-related macular degeneration: Epidemiology, genetics ...Macular degeneration is the leading cause of severe, irreversible vision loss in people over age 55. It occurs when the macula deteriorates. Because the disease ...
Phase 1 Clinical Trial of Elamipretide in Intermediate Age- ...Epidemiology of age-related · macular degeneration (AMD): associations with cardiovascu- · lar disease phenotypes and lipid factors. Eye Vis ( ...
Evidence-Based Practice and Trends in Visual ...Age-related macular degeneration (AMD) is a common, chronic, and progressive eye disease that is considered the leading cause of visual loss among the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security